Cargando…
α-Glucosidase and Bacterial β-Glucuronidase Inhibitors from the Stems of Schisandra sphaerandra Staph
α-Glucosidase (AGS) is a therapeutic target for Type 2 diabetes mellitus (T2DM) that tends to complicate with other diseases. Some medications for the treatment of T2DM complications have the risk of inducing severe adverse reactions such as diarrhea via the metabolism of intestinal bacterial β-gluc...
Autores principales: | Rao, Guiwei, Yu, Hangfei, Zhang, Manlai, Cheng, Yuchen, Ran, Kun, Wang, Jianwei, Wei, Bin, Li, Min, Shan, Weiguang, Zhan, Zhajun, Ying, Youmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954508/ https://www.ncbi.nlm.nih.gov/pubmed/35337127 http://dx.doi.org/10.3390/ph15030329 |
Ejemplares similares
-
α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes
por: Lu, Xuejun, et al.
Publicado: (2023) -
Eating Staph
por: Tuma, Rabiya S.
Publicado: (2005) -
How staph thwarts attack
por: Maxmen, Amy
Publicado: (2009) -
Methicillin-sensitive Staph. aureus (MSSA) and methicillin-resistant Staph. aureus (MRSA) bacteraemia decline simulaneously
por: Coello, R, et al.
Publicado: (2011) -
Assessment of gut microbial β-glucuronidase and β-glucosidase activity in women with polycystic ovary syndrome
por: Patel, Jalpa, et al.
Publicado: (2023)